【24h】

HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth

机译:基于HPMA的聚合物胶束,用于姜黄素增溶和抑制癌细胞生长

获取原文
获取原文并翻译 | 示例
       

摘要

Curcumin (CM) has been reported as a potential anticancer agent. However, its pharmaceutical applications as therapeutic agent are hampered because of its poor aqueous solubility. The present study explores the advantages of polymeric micelles composed of block copolymers of methoxypoly(ethylene glycol) (mPEG) and N-(2-hydroxypropyl) methacrylamide (HPMA) modified with monolactate, dilactate and benzoyl side groups to enhance CM solubility and inhibitory activity against cancer cells. Amphiphilic block copolymers, omega-methoxypoly(ethylene glycol)-b-(N-(2-benzoyloxypropyl) methacrylamide) (PEG-HPMA-Bz) were synthesized and characterized by H-1 NMR and GPC. One polymer with a molecular weight of 28,000 Da was used to formulate CM and compared with other aromatic substituted polymers. CM was loaded by a fast heating method (PEG-HPMA-DL and PEG-HPMA-Bz-L) and a nanoprecipitation method (PEG-HPMA-Bz). Physicochemical characteristics and cytotoxicity/cytocompatibility of the CM loaded polymeric micelles were evaluated. It was found that HPMA-based polymeric micelles significantly enhanced the solubility of CM. The PEG-HPMA-Bz micelles showed the best solubilization properties. CM loaded polymeric micelles showed sustained release of the loading CM for more than 20 days. All of CM loaded polymeric micelles formulations showed a significantly potent cytotoxic effect against three cancer cell lines. HPMA-based polymeric micelles are therefore promising nanodelivery systems of CM for cancer therapy. (C) 2015 Elsevier B.V. All rights reserved.
机译:姜黄素(CM)已被报道为潜在的抗癌药。但是,由于其水溶性差,因此阻碍了其作为治疗剂的药物应用。本研究探索了由单乳酸,二乳酸和苯甲酰基侧基改性的甲氧基聚乙二醇(mPEG)和N-(2-羟丙基)甲基丙烯酰胺(HPMA)的嵌段共聚物组成的聚合物胶束的优势,以增强CM的溶解性和抑制活性针对癌细胞。合成了两亲嵌段共聚物,ω-甲氧基聚(乙二醇)-b-(N-(2-苯甲酰氧基丙基)甲基丙烯酰胺)(PEG-HPMA-Bz),并通过H-1 NMR和GPC表征。使用一种分子量为28,000 Da的聚合物配制CM,并将其与其他芳族取代的聚合物进行比较。通过快速加热方法(PEG-HPMA-DL和PEG-HPMA-Bz-L)和纳米沉淀法(PEG-HPMA-Bz)加载CM。评价了负载CM的聚合物胶束的理化特性和细胞毒性/细胞相容性。发现基于HPMA的聚合物胶束显着增强了CM的溶解性。 PEG-HPMA-Bz胶束表现出最佳的增溶性能。 CM负载的聚合物胶束显示出负载CM的持续释放超过20天。所有载有CM的聚合物胶束制剂均显示出对三种癌细胞的显着有效的细胞毒性作用。因此,基于HPMA的聚合物胶束有望用于癌症治疗的CM纳米递送系统。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号